Skip to main content
Topics
Video
Provider
Payer
Pharma
ANZ
ASIA
EMEA
Global Edition
heart failure
Restore Medical secures $23M for heart failure studies
By
Anthony Vecchione
|
02:12 pm |
July 08, 2025
The company will use the funds for a European feasibility study for its transcatheter device and for the launch of a U.S.-based clinical study.